A phase I clinical and pharmacokinetic study of Ro 31-7453 given as a 7- or 14-day oral twice daily schedule every 4 weeks in patients with solid tumors
| Image |  |
|---|---|
| Description | scientific article published in July 2004 |
| Author/s |
author: Chris Twelves |
| Publication date | July 1, 2004 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |